Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer
/PRNewswire/ -- Verismo Therapeutics, Inc., a recent Penn spin-out behind a novel multichain KIR-CAR platform technology for CAR T-cells, today announced the...
Source: prnewswire.com